The objective of the EFOMP Special Interest Group for Radionuclide Internal Dosimetry (SIG) is to establish a network of medical physicists working in radionuclide dosimetry. The SIG aims to fulfil the need for networking, education, research and professional exchanges in this field. To fulfil these aims, EFOMP SIG_FRID will organise a Symposium on molecular radiotherapy dosimetry in Athens, Greece.
The Symposium will give the opportunity:
- to review and share ongoing developments in radionuclide imaging and dosimetry;
- to consider how personalised treatments may improve effectiveness at a time of rapid expansion of theragnostics and molecular radiotherapy
- to discuss networking and synergies within a muti-disciplinary community at a time of challenge and opportunity.
Invited Speakers (preliminary list – more to come…)
Institut Curie, Orsay, France
AI: a game changer in quantitative molecular imaging and clinical dosimetry
University College of London, UK
Can dosimetry improve the outcome of molecular radiotherapy for neuroblastoma?
Oslo University Hospital, Norway
Implementation of Dosimetry for Radionuclide Therapy: Results from a European Survey
Royal Marsden Hospital, Sutton, UK
Quantitative imaging and dosimetry of radioiodine in multi-centre clinical trials
Istituto Nazionale Tumori, Milan, Italy
Dosimetry and clinical outcome in radioembolization: light and shadow
Institut de Recherche en Cancérologie de Montpellier, France
Implementing QA in clinical dosimetry
University of Ulm, Germany
Time-Activity Data, Model Fitting and Model Selection in Molecular Radiotherapy Dosimetry
23 Registered Participants
Argyriadis hall – National and Kapodistrian University of Athens,
30 Panepistimiou Str., 10679, Athens